期刊文献+

6-喹唑啉酮甲酯衍生物的合成研究

Synthesis of 6-Carboxyquinazolinone Derivatives
下载PDF
导出
摘要 喹唑啉酮及其衍生物是一类具有广泛生物活性的化合物。本文以2,4-二甲基苯胺为起始原料,经乙酰化、氧化、甲酯化、关环、取代等反应,设计合成了一系列新型的6-甲酯-2-氯甲基(或三氟甲基)-3-芳基-4-喹唑啉酮衍生物,所有目标化合物均测定了熔点,并用1H-NMR和质谱进行结构表征。进一步实验发现,该喹唑啉酮衍生物很难通过水解的方法得到相应的羧酸。 Quinazolinone and its derivatives often display excellent bio-activities. The synthesize route of methyl 2-( chloromethyl or trifluoromethyl)-3-( phenyl)-4-oxo-quinazoline-6-carboxylate derivatives was undergone acetylation,oxidation,methylation,cyclization and substitution reactions from the starting 2,4-dimethylaniline. All of the target compounds were confirmed by1 HNMR,MS and melting point. These series compounds were very difficult for further reaction of hydrolysis to get corresponding carboxylic acid.
作者 侯松昆 徐玉玲 陈晶晶 HOU Song-kun;XU Yu-ling;CHEN Jing-jing(School of Chemical & Environmental Engineering,Wuhan Polytechnic University,Hubei Wuhan 430023,Chin)
出处 《广州化工》 CAS 2018年第14期22-23,42,共3页 GuangZhou Chemical Industry
基金 武汉轻工大学科研项目资助(No:2017y19)
关键词 喹唑啉酮 取代 衍生物 甲酯 quinazolinone substitution derivatives methyl ester
  • 相关文献

参考文献1

二级参考文献28

  • 1CARMI C, MOR M, PETRONINI P G, et al. Clinical perspec- tives for irreversible tyrosine kinase inhibitors in cancer[ J]. Bio- chem Pharmacol, 2012, 84( 11 ) :1388-1399.
  • 2Boehringer Ingelheim Pharma. Quinazoline derivatives, medica- ments containing said compounds, their utilization and method for the production thereof: Germany, WO 0250043A1 [ P]. 2002-06- 27.
  • 3Boehringer Ingelheim Pharma. Utilization inhibitors EGFR-media- ted signal transduction for the treatment benign prostatic hyperpla- sia ( BPH)/prostatic hypertrophy: Germany, WO03094921A2 [P]. 2003-11-20.
  • 4XU X N. The preparation Afatinib: China, 201310173504. 9 [ P]. 2013-8-21.
  • 5XU X N. The preparation Afatinib: China, 201310180796. 9 [P]. 2013-9-11.
  • 6XU X N. The preparation the intermediate 4-chloro-6-amino-7- hydroxy quinazoline : China, 201310181198. 3 [ P]. 2013-9-11.
  • 7XU X N. The preparation Afatinib: China, 201310182778. 4 [ P]. 2013-8-14.
  • 8ZHANG X, PENG T, JI X, et al. Design, synthesis and biologi- cal evaluation novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors the epidermal growth factor receptor[ J]. Bioorg Med Chem, 2013, 21 (24) :7988-7998.
  • 9JI X, PENG T, ZHANG X, et al. Design, synthesis and biologi- cal evaluation novel 6-alkenylamides substituted 4-anilinothieno [ 2,3-d ] pyrimidines as irreversible epidermal growth factor recep- torinhibitors[J]. Bioorg ned Chem, 22(7):2014, 22(7): 2366-2378.
  • 10SOLCA F, DAHL G, ZOEPHEL A, et al. Target binding proper-ties and cellular activity afatinib ( BIBW 2992 ) , an irreversible ErbB family blocker [ J ]. J Pharmacol Exp Ther, 2012, 343 ( 2 ) : 342-350.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部